Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Mar
7
2012
New FDA Research Consent Form Requirements – Effective Today Mintz
May
28
2012
Revised Draft Regulations Postpone Compliance with California’s Nonresidential Building Energy Use Disclosure Program Mintz
Jan
21
2013
Energy & Clean Tech Connections – January 2013 Edition Mintz
May
15
2013
Energy & Environmental Law Update May 13, 2013 Mintz
Jun
4
2013
Farm Bill Amendments, Presidential Nominees, and the Shaheen-Portman Energy Efficiency Bill Mintz
May
14
2018
President Trump Delivers Much Anticipated Drug Pricing Speech Mintz
Jul
16
2013
The House Takes Action on Energy Legislation, and Senate Leader Forces Vote on Presidential Nominations Mintz
Sep
10
2021
Biden Administration Unveils Sweeping Workplace Vaccination Plan Mintz
Oct
24
2013
National Institute of Standards and Technology (NIST) Publishes Preliminary Federal Cybersecurity “Framework” for Comment Mintz
Oct
17
2018
Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads Mintz
Dec
18
2013
Energy and Environmental Law Update - December 17, 2013 Mintz
Oct
23
2018
Six Initiatives States May Pursue to Curb Drug Prices and the 340B Factor Mintz
Feb
26
2014
Houston-Based SURGE Accelerator and the Success of Startup Accelerators Mintz
Apr
8
2014
Energy & Environmental Law Update - April 7. 2014 Mintz
Feb
6
2019
OIG Advisory Opinion Allows Smartphone Loan for Needy Patients Taking Digital Drug Mintz
Jun
13
2014
U.S. Supreme Court: Pom’s Mislabeling Suit Against Coke Not Precluded by FDA Regulations - Food and Drug Administration Mintz
May
4
2022
Final Medicare Advantage and Part D Rule will Likely Require Medicare Advantage Plans to Update 2023 Bids under Maximum Out-of-Pocket (MOOP) Policy Changes Mintz
Aug
22
2014
Office of Inspector General (OIG) Finds Risk of Abuse in Specialty Pharmacy’s Per-Fill Fee Proposal Mintz
Jun
2
2022
Summer 2022 Is Here – Do You Know How the FDA User Fee Legislation Is Going? Mintz
Sep
2
2014
The Increasingly Murky World of 340B Drug Discount Program: What’s Next? Mintz
Sep
23
2014
Energy & Environmental Law Update -- September 22, 2014 Mintz
Oct
9
2014
Proposed Rule Issued by HHS Office of the Inspector General (OIG) Realigns Its Enforcement Views with Health Care Reform Goals Mintz
Oct
17
2014
The Incredible Shrinking Red Bull Refund: How Should Courts Verify Class Membership? Mintz
Oct
23
2014
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 23, 2014 Mintz
Jan
15
2015
Pharmacy Qui Tam Based On U&C Price Billing Survives Motion to Dismiss Mintz
Sep
29
2022
MintzRx — Drug Pricing Update: The Inflation Reduction Act Mintz
Apr
9
2015
Food Labeling, Food Safety and Nutrition Update Mintz
Apr
16
2015
FDA Increasing Scrutiny of Cosmetic Marketing Claims, New Agency Warnings Suggest Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins